Mahoney Stephen F.

Mahoney Stephen F. is listed in filings as President and CEO at Viridian Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 9, 2026, including purchase activity. Recent filings connect the profile to Viridian Therapeutics, Inc. (VRDN). The current snapshot covers public activity from Sep 30, 2024 to Mar 9, 2026. Reported amounts are shown as $499.3K to $223.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.